[go: up one dir, main page]

Luo et al., 2018 - Google Patents

Biomarkers of liver-cancer discovered from the male patients crude serum without depletion of high abundance proteins

Luo et al., 2018

View PDF
Document ID
4426022792074891439
Author
Luo L
Lin Z
Zeng X
Huang H
Publication year
Publication venue
Cancer Rep. Rev

External Links

Snippet

High abundance proteins (HAP) were often removed from crude serum sample when finding biomarkers of diagnosing cancers, however, it will surely filtrate many potential biomarkers bound to HAP. In order to enable the detection of these potential biomarkers, saving the …
Continue reading at www.siriusstore.com (PDF) (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6842—Proteomic analysis of subsets of protein mixtures with reduced complexity, e.g. membrane proteins, phosphoproteins, organelle proteins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G01N33/574—Immunoassay; Biospecific binding assay for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57415—Specifically defined cancers of breast
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6848—Methods of protein analysis involving mass spectrometry
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N27/00—Investigating or analysing materials by the use of electric, electro-chemical, or magnetic means

Similar Documents

Publication Publication Date Title
Steel et al. A strategy for the comparative analysis of serum proteomes for the discovery of biomarkers for hepatocellular carcinoma
Rui et al. Use of serological proteomic methods to find biomarkers associated with breast cancer
Kreunin et al. Identification of metastasis‐associated proteins in a human tumor metastasis model using the mass‐mapping technique
JP2001508864A (en) A method for detecting the state of an organism by measuring a peptide
JP4307249B2 (en) Use of soluble cytokeratin 1 fragments in diagnosis and therapy
KR101219519B1 (en) A method for the diagnosis using lectin
KR20200028510A (en) Srm assays to chemotherapy targets
JP5576302B2 (en) Plasma biomarker for liver cancer diagnosis containing liver carboxylesterase 1 and liver cancer screening method
WO2009006382A1 (en) Detection of glycopeptides and glycoproteins for medical diagnostics
EP2444814B9 (en) Biomarker for mental disorders including cognitive disorders, and method using said biomarker to detect mental disorders including cognitive disorders
Panicker et al. Characterization of the human cervical mucous proteome
CA2823337C (en) Her3 protein srm/mrm assay
EP3092495B1 (en) Srm assay for pd-l1
US20060068452A1 (en) Differential protein expression patterns related to disease states
US8642347B2 (en) Urinary CA125 peptides as biomarkers of ovarian cancer
Byrjalsen et al. Human endometrial proteins with cyclic changes in the expression during the normal menstrual cycle: characterization by protein sequence analysis
JP2001501300A (en) Biochemical markers of human endometrium
Luo et al. Biomarkers of liver-cancer discovered from the male patients crude serum without depletion of high abundance proteins
EP2517002A1 (en) Insulin receptor substrate 1 (irs1) protein srm/mrm assay
US7235368B2 (en) CHP for use as marker for sepsis-type inflammatory diseases
EP3137631A1 (en) Srm/mrm assay for the tyrosine-protein kinase receptor ufo (axl) protein
KR101712368B1 (en) Highly sensitive cancer marker analysing method by glycan monitoring of glycoprotein through intact molecular weighing
CN110568195B (en) Urine protein marker related to glioblastoma and application thereof
WO2015168483A1 (en) Srm/mrm assay for the androgen receptor (ar) protein
KR101535717B1 (en) Composition for pancreatic cancer diagnosis comprising complememt factor i-specific binding polypeptide or antibody